We partner with the media to inform the public of the global human crisis.
June 30, 2020US Government Agreement with Former CEO...
June 29, 2020Appointment of Chief Executive Officer...
June 24, 2020New Data from the RECOVER™ Study Reveal Two-Year Outcomes in People with Opioid Use Disorder Following Transition from Pivotal Phase 3 Clinical Trials to a Real-World Setting...
June 3, 2020Indivior Announces Patent Trial and Appeal Board Ruling in Dr. Reddy’s Laboratories (DRL)’s Petition for Inter Partes Review of U.S. Patent No. 9,687,454 (the ‘454 Patent)...
May 14, 2020Q1 2020 Indivior Financial Results Press Release...
The information provided below is provisional and subject to change. Details of each event, including venue information, will be confirmed shortly before they are due to take place.
Global Media Contacts
EMEA, Australasia and China Financial Disclosure Reporting
Disclosure Of Payments, Donations & Joint Working
The Online Press Kit is designed to help media research our company for background information or follow-up stories. Please visit the links below to learn more.
About Indivior PLC – An overview of Indivior, including our worldwide locations and key products
Board of Directors – Biographies of Indivior’s Board
The Indivior PLC Pipeline – Information about the Indivior R&D efforts and progress of medicines in the pipeline